Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-TRC-08000038Phase 4Recruiting
Phase 4, randomised trial of diclofenac and glucosamine sulphate in Kashin-Beck disease (KBD) (4 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Improvement of pain and Multiple indices. Started Jan 2008; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-TRC-08000038.